Cargando…
Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator Against Drug-Resistant Tuberculosis
Drug-resistant tuberculosis is quickly emerging as one of the largest threats to the global health community. Current chemotherapy for tuberculosis dates back to the 1950s and is arduous, lengthy, and remains extremely difficult to complete in many of the highest burdened areas. This causes inadequa...
Autor principal: | Smith, Jonathan Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238330/ https://www.ncbi.nlm.nih.gov/pubmed/22180674 |
Ejemplares similares
-
Introduction
por: Zhao, Peter, et al.
Publicado: (2011) -
Radioimmunotherapy of Non-Hodgkin’s Lymphoma: From the ‘Magic Bullets’ to ‘Radioactive Magic Bullets’
por: Chamarthy, Murthy R., et al.
Publicado: (2011) -
Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
por: Mansh, Matthew
Publicado: (2011) -
Regulating Caspase-1 During Infection: Roles of NLRs, AIM2, and ASC
por: Case, Christopher L.
Publicado: (2011) -
Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear
por: Dimberu, Peniel M., et al.
Publicado: (2011)